Metformin is designed to lower blood glucose levels in people with type 2 diabetes.
And the company, “Nostrum Laboratories Inc. “, based in Kansas City, Missouri, USA, announced on Monday that it voluntarily withdrew” metformin HCl “tablets, according to the US Food and Drug Administration.
Tests on the drug revealed levels of nitrosamine, or “NDMA,” above the acceptable threshold for the recalled tablets.
The chemical “NDMA” is considered a potential carcinogen by the US Environmental Protection Agency. It is an organic chemical used in making liquid rocket fuel, and it could be a byproduct of manufacturing, including drug manufacturing.
This is the latest recall of metformin, which is linked to a potentially cancer-causing contaminant in the drugs.
The company “Nostrum” stated that it had not received any reports of negative events related to the withdrawal of the drug, and the company also said that it notifies its distributors and arranges to return the recovered product.
More than 34 million people in the United States suffer from diabetes, or about one in 10, with about 90 to 95% of them diagnosed with type 2 diabetes, according to the US Centers for Disease Control and Prevention.
These were the details of the news Withdrawal of the drug “metformin” to treat diabetes … what is... for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at saudi24news and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.
